1. P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA. (23rd June 2022) Authors: Von Roemeling, C.; Iqbal, M.; Doonan, B.; Hoang-Minh, L.; Klippel, K.; Tun, H.; Mitchell, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗